Dr. Marie Trad, M.D., Chief Medical Officer is responsible for Lysogene’s medical and clinical development activities. With over thirty years of clinical and pharmaceutical development experience in the field of neurological diseases, she brings her in-depth knowledge and expertise to lead Lysogene’s gene therapy pipeline global clinical development from early stages throughout the lifecycle up to post-marketing stages. After over a decade of clinical practice, Dr. Trad joined the bio-pharmaceutical industry in 2000 in varied senior strategic roles, both in Biopharma and CROs during which period she, supported multiple NDAs, in different neurological indications. Dr. Trad is a board-certified neurologist and a qualified neuroradiologist from the Pierre and Marie Curie University, Paris, France.